Related Experiment Video
Updated: May 6, 2026

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline
Published on: November 29, 2016
RTK/ERK pathway under natural selection associated with prostate cancer
Yang Chen1, Xianxiang Xin, Jie Li
1Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China ; Department of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Prostate cancer risk is linked to the RTK/ERK pathway influenced by natural selection. Specific genes and SNPs, like rs17172432, may be key drivers in prostate cancer (PCa) development.
Area of Science:
- Genetics
- Oncology
- Evolutionary Biology
Background:
- Prostate cancer (PCa) is a significant global health concern with high mortality.
- The RTK/ERK pathway is implicated in PCa development, but its evolutionary mechanisms are not fully understood.
Purpose of the Study:
- To investigate the association between the RTK/ERK pathway, genetic variations, and prostate cancer risk.
- To explore the role of natural selection in the evolution of PCa susceptibility.
Main Methods:
- Combined genotypic and phenotypic data from the ChinaPCa consortium with public databases.
- Performed expression of quantitative trait loci (eQTLs) analysis, natural selection analysis, and gene-based pathway analysis.
Main Results:
- Pathway analysis confirmed a positive correlation between PCa risk and several key genes.
- Four genes (EGFR, ERBB2, PTK2, RAF1) and five SNPs, particularly rs17172432, were identified as potentially pivotal in PCa development under natural selection.
- The RTK/ERK pathway, influenced by natural selection, appears critical in modulating PCa risk.
Conclusions:
- The interplay between the RTK/ERK pathway, natural selection, and specific genetic loci contributes to prostate cancer risk.
- Understanding these combined effects may offer insights into PCa prevention and therapeutic strategies.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Receptor Tyrosine Kinases
PI3K/mTOR/AKT Signaling Pathway
The Ras Gene
Ras is a...

